Skip to content

Epidemiological study of chronic obstructive pulmonary disease (COPD) using health insurance claims data and health examination data

Epidemiological study of chronic obstructive pulmonary disease (COPD) using health insurance claims data and health examination data - Epidemiological study of COPD using health insurance claims data and health examination data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049532
Enrollment
60000
Registered
2022-11-16
Start date
2022-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

None listed

Sponsors

Kracie, Ltd.
Lead Sponsor
JMDC Inc
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Target Group (1) (i) Have had at least one medical checkup between January 2017 and December 2019 (ii) Enrolled for one year in the year of the checkup (iii) Aged 40 years or older at the time of the checkup (iv) FEV1% and FEV1 have been measured Target Group (2) (i) Have a medical checkup in each year (3 years) from January 2017 to December 2019 (ii) Have been enrolled for three years from January 2017 (iii) Aged 40 years or older as of January 2017 (iv) Have airflow limitation as of 2017 (v) Have had FEV1% and FEV1 measured continuously for 3 years

Exclusion criteria

Exclusion criteria: No setting

Design outcomes

Primary

MeasureTime frame
Prevalence of airflow limitation and COPD diagnosis rate

Secondary

MeasureTime frame
- Percentage of patients by severity of airflow limitation using %FEV1 - FEV1%, FEV1, prevalence of disease, and prescription drugs by COPD diagnosis - FEV1%, FEV1, and prevalence of disease by frailty classification - FEV1% and FEV1 by COPD diagnosis and smoking status over 3 years

Countries

Japan

Contacts

Public ContactYuka Koga

Kracie, Ltd. Pharmaceutical Research Promotion Department, Pharmaceutical Division

koga_yuka@kracie.co.jp03-5446-3352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026